Episode Details

Back to Episodes

The Health Marketing Daily | Mikrobiom-Modulation als Therapieansatz beim Reizdarmsyndrom | Ferrero to buy better-for-you breakfast brand | FDA lays out plan to close

Published 1 month, 2 weeks ago
Description
The Health Marketing Daily — August 17, 2026 In this episode: • Germany's updated S3 clinical guideline on IBS now formally recognises microbiome modulation as a therapeutic approach — a significant validation moment for probiotic and gut health brands operating in Europe's largest market. • Ferrero's acquisition of Purely Elizabeth signals that major confectionery incumbents are now aggressively buying into the better-for-you breakfast and wellness food space — not just dabbling at the edges. • The FDA's move to close the GRAS self-determination loophole — requiring mandatory notification for ingredients previously self-affirmed as safe — is the most significant US food ingredient regulatory shift in decades, with downstream implications for functional food and supplement formulation globally. • Khloé Kardashian's Khloud brand is taking collagen — long a premium supplement category — into mass-market snack format via a Walmart-exclusive launch, signalling a major channel and format shift for functional ingredients. Hosted by Marco & Klara. New episode every weekday. Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us